Form D · Other Health Care
Emerald Therapeutics, Inc.
Menlo Park, CA · CIK 0001501852
Offering snapshot reported Feb 21, 2014 · SEC filing
- Reported sold
- $5.61M Offering amount: $6M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 7, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 21, 2014 | Initial | $5,609,997 | No comparison | 5 | SEC filing |
| Mar 29, 2012 | Initial | $1,000,000 | No comparison | 4 | SEC filing |
| Dec 22, 2010 | Amendment | $5,000,003 | $1,550,002vs Sep 27, 2010 | 14 | SEC filing |
| Sep 27, 2010 | Initial | $3,450,001 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-212307
Source: Form D, filed Feb 21, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Frezza | Director, Executive |
| Daniel J. Kleinbaum | Director, Executive |
| Max R. Levchin | Director |
| Luke Nosek | Director |
| Brian Singerman | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3745 M Edison Way
Menlo Park, CA, 94025
Menlo Park, CA, 94025